During the past decade, Front Range Cancer Specialists conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 56 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Front Range Cancer Specialists" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 29 trials, followed by "SWOG Cancer Research Network" with 13 trials sponsored, "Eastern Cooperative Oncology Group" with 11 trials sponsored, "National Cancer Institute (NCI)" with 8 trials sponsored and "NSABP Foundation Inc" with 8 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Front Range Cancer Specialists" #1 collaborator was "National Cancer Institute (NCI)" with 70 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator and "Eastern Cooperative Oncology Group" with 5 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Front Range Cancer Specialists" are "Breast Cancer" (24 trials), "Lung Cancer" (12 trials), "Lymphoma" (8 trials), "Colorectal Cancer" (5 trials) and "Pancreatic Cancer" (5 trials). Many other conditions were trialed in "Front Range Cancer Specialists" in a lesser frequency.

Most popular intervention types in "Front Range Cancer Specialists" are "Drug" (75 trials), "Biological" (28 trials), "Other" (26 trials), "Radiation" (11 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (14 trials), "bevacizumab" (12 trials), "carboplatin" (8 trials), "cetuximab" (7 trials) and "cisplatin" (7 trials). Other intervention names were less common.

The vast majority of trials in "Front Range Cancer Specialists" are 64 trials for "All" genders, 20 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Front Range Cancer Specialists". undefined are not yet recruiting, undefined are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 72 completed trials in Front Range Cancer Specialists, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Front Range Cancer Specialists, 2 "Phase 1" clinical trials were conducted, 38 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".